Search Results - "Surova, Yulia"

CSF biomarkers and clinical progression of Parkinson disease by Hall, Sara, Surova, Yulia, Öhrfelt, Annika, Zetterberg, Henrik, Lindqvist, Daniel, Hansson, Oskar

“…OBJECTIVE:To investigate whether certain CSF biomarkers at baseline can predict future progression of motor symptoms and cognitive decline in patients with…”
Get full text

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease by Hall, Sara, Surova, Yulia, Öhrfelt, Annika, Blennow, Kaj, Zetterberg, Henrik, Hansson, Oskar

“…ABSTRACT Objective The purpose of this study was to investigate whether cerebrospinal fluid (CSF) levels of tau, phosphorylated tau, β‐amyloid42, α‐synuclein,…”
Get full text

Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum by Lindqvist, Daniel, Kaufman, Eli, Brundin, Lena, Hall, Sara, Surova, Yulia, Hansson, Oskar

“…Parkinson's Disease (PD) is the second most common neurodegenerative disorder of the central nervous system. Motor symptoms are the focus of pharmacotherapy,…”
Get full text

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders by Hall, Sara, Janelidze, Shorena, Surova, Yulia, Widner, Håkan, Zetterberg, Henrik, Hansson, Oskar

“…Inflammation has been implicated in the pathogenesis of Parkinson’s disease (PD). We here investigate levels of inflammatory biomarkers in cerebrospinal fluid…”
Get full text

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies by Wennström, Malin, Surova, Yulia, Hall, Sara, Nilsson, Christer, Minthon, Lennart, Hansson, Oskar, Nielsen, Henrietta M

“…A major difference in the revised diagnostic criteria for Alzheimer's disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow…”
Get full text

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy by Wennström, Malin, Surova, Yulia, Hall, Sara, Nilsson, Christer, Minthon, Lennart, Boström, Fredrik, Hansson, Oskar, Nielsen, Henrietta M

“…Neurosin is a protease that in vitro degrades α-synuclein, the main constituent of Lewy bodies found in brains of patients with synucleinopathy including…”
Get full text

Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders by Hall, Sara, Janelidze, Shorena, Zetterberg, Henrik, Brix, Britta, Mattsson, Niklas, Surova, Yulia, Blennow, Kaj, Hansson, Oskar

“…Background CSF concentration of neurogranin has been suggested as a biomarker for synapse dysfunction. Objectives To investigate CSF neurogranin in…”
Get full text

Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease by Surova, Yulia, Lampinen, Björn, Nilsson, Markus, Lätt, Jimmy, Hall, Sara, Widner, Håkan, van Westen, Danielle, Hansson, Oskar

“…In Parkinson's disease (PD), pathological microstructural changes occur and such changes might be detected using diffusion magnetic resonance imaging (dMRI)…”
Get full text

Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy by Kaufman, Eli, Hall, Sara, Surova, Yulia, Widner, Håkan, Hansson, Oskar, Lindqvist, Daniel

“…Despite several lines of evidence from preclinical and post-mortem studies suggesting that inflammation is involved in Multiple System Atrophy (MSA), no…”
Get full text

Alteration of putaminal fractional anisotropy in Parkinson’s disease: a longitudinal diffusion kurtosis imaging study by Surova, Yulia, Nilsson, Markus, Lampinen, Björn, Lätt, Jimmy, Hall, Sara, Widner, Håkan, van Westen, Danielle, Hansson, Oskar

“…Purpose In Parkinson’s disease (PD), pathological microstructural changes occur that may be detected using diffusion magnetic resonance imaging (dMRI)…”
Get full text

Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism by Sjöström, Henrik, Surova, Yulia, Nilsson, Markus, Granberg, Tobias, Westman, Eric, van Westen, Danielle, Svenningsson, Per, Hansson, Oskar

“…There is a need for methods that distinguish Parkinson’s disease (PD) from progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), which have…”
Get full text

Assessment of global and regional diffusion changes along white matter tracts in parkinsonian disorders by MR tractography by Surova, Yulia, Szczepankiewicz, Filip, Lätt, Jimmy, Nilsson, Markus, Eriksson, Bengt, Leemans, Alexander, Hansson, Oskar, van Westen, Danielle, Nilsson, Christer

“…The aim of the study was to determine the usefulness of diffusion tensor tractography (DTT) in parkinsonian disorders using a recently developed method for…”
Get full text

Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment by Lindqvist, Daniel, Hall, Sara, Surova, Yulia, Nielsen, Henrietta M, Janelidze, Shorena, Brundin, Lena, Hansson, Oskar

“…Highlight • High levels of inflammatory markers in cerebrospinal fluid were associated with fatigue, depression, and cognitive impairment in patients with…”
Get full text

P3‐270: CEREBROSPINAL FLUID CONCENTRATIONS OF INFLAMMATORY MARKERS IN PARKINSON'S DISEASE AND ATYPICAL PARKINSONIAN DISORDERS by Hall, Sara, Janelidze, Shorena, Surova, Yulia, Widner, Håkan, Zetterberg, Henrik, Hansson, Oskar

Get full text

CEREBROSPINAL FLUID CONCENTRATIONS OF INFLAMMATORY MARKERS IN PARKINSON’S DISEASE AND ATYPICAL PARKINSONIAN DISORDERS by Hall, Sara, Janelidze, Shorena, Surova, Yulia, Widner, Håkan, Zetterberg, Henrik, Hansson, Oskar

Get full text

L ongitudinal M easurements of C erebrospinal F luid B iomarkers in P arkinson's D isease by Hall, Sara, Surova, Yulia, Öhrfelt, Annika, Blennow, Kaj, Zetterberg, Henrik, Hansson, Oskar

“…ABSTRACT Objective The purpose of this study was to investigate whether cerebrospinal fluid (CSF) levels of tau, phosphorylated tau, β‐amyloid 42 ,…”
Get full text

P1‐144: HIGH CSF A‐SYNUCLEIN IS ASSOCIATED WITH CLINICAL PROGRESSION IN PD PATIENTS by Lindqvist, Daniel, Hall, Sara, Surova, Yulia, Öhrfelt, Annika, Hansson, Oskar

Get full text

HIGH CSF A-SYNUCLEIN IS ASSOCIATED WITH CLINICAL PROGRESSION IN PD PATIENTS by Lindqvist, Daniel, Hall, Sara, Surova, Yulia, Öhrfelt, Annika, Hansson, Oskar

Get full text

Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy by Surova, Yulia, Nilsson, Markus, Lätt, Jimmy, Lampinen, Björn, Lindberg, Olof, Hall, Sara, Widner, Håkan, Nilsson, Christer, van Westen, Danielle, Hansson, Oskar

“…Introduction The aim of this study is to identify disease-specific changes of the thalamus, basal ganglia, pons, and midbrain in patients with progressive…”
Get full text

Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion by Knutsson, Linda, Lindgren, Emelie, Ahlgren, André, van Osch, Matthias J.P., Bloch, Karin Markenroth, Surova, Yulia, Ståhlberg, Freddy, van Westen, Danielle, Wirestam, Ronnie

“…Purpose Arterial partial‐volume effects (PVEs) often hamper reproducible absolute quantification of cerebral blood flow (CBF) and cerebral blood volume (CBV)…”
Get full text